Redox control of G1/S cell cycle regulators during nitric oxide-mediated cell cycle arrest

Journal of Cellular Physiology

Volumn 212, Issue 3, 2007, Pages 827-839

  Lu, Q I ^a   Jourd'Heuil, Frances L ^a   Jourd'Heuil, David ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; NITRIC OXIDE; PIFITHRIN ALPHA; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROTECTION; CONTROLLED STUDY; CYTOSTASIS; DNA DAMAGE; ENZYME INHIBITION; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

ANIMALS; BENZOTHIAZOLES; BUTHIONINE SULFOXIMINE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FIBROBLASTS; G1 PHASE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; MICE; NIH 3T3 CELLS; NITRIC OXIDE; NITRIC OXIDE DONORS; OXIDATION-REDUCTION; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; S PHASE; TOLUENE; TRANSFECTION; TRIAZENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34547950953     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21079     Document Type: Article

References (47)

1. Amber IJ, Hibbs JBJr, Taintor RR, Vavrin Z. 1988. The L-arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages. J Leukoc Biol 43:187-192.
2. Beltran B, Orsi A, Clementi E, Moncada S. 2000. Oxidative stress and S-nitrosylation of proteins in cells. Br J Pharmacol 129:953-960.
3. Brooks CL, Gu W. 2006. p53 ubiquitination: Mdm2 and beyond. Mol Cell 21:307-315.
4. Deshpande A, Sicinski P, Hinds PW. 2005. Cyclins and cdks in development and cancer: A perspective. Oncogene 24:2909-2915.
5. Dhar A, Brindley JM, Stark C, Citro ML, Keefer LK, Colburn NH. 2003. Nitric oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther 2:1285-1293.
6. Green RM, Graham M, O'Donovan MR, Chipman JK, Hodges NJ. 2006. Subcellular compartmentalization of glutathione: Correlations with parameters of oxidative stress related to genotoxicity. Mutagenesis 21:383-390.
7. Grisham MB, Jourd'Heuil D, Wink DA. 1999. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am J Physiol 276:G315-G321.
8. Hammond EM, Dorie MJ, Giaccia AJ. 2003. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 278:12207-12213.
9. Hofseth LJ, Hussain SP, Wogan GN, Harris CC. 2003a. Nitric oxide in cancer and chemoprevention. Free Radic Biol Med 34:955-968.
10. Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP, Quezado MM, Zurer I, Rotter V, Wink DA, Appella E, Harris CC. 2003b. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 100:143-148.
11. Hothersall JS, Cunha FQ, Neild GH, Norohna-Dutra AA. 1997. Induction of nitric oxide synthesis in J774 cells lowers intracellular glutathione: Effect of modulated glutathione redox status on nitric oxide synthase induction. Biochem J 322:477-481.
12. Hussain SP, Trivers GE, Hofseth LJ, He P, Shaikh I, Mechanic LE, Doja S, Jiang W, Subleski J, Shorts L, Haines D, Laubach VE, Wiltrout RH, Djurickovic D, Harris CC. 2004. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res 64:6849-6853.
13. Jourd'Heuil D, Jourd'Heuil FL, Feelisch M. 2003. Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. Evidence for a free radical mechanism. J Biol Chem 278:15720-15726.
14. Jourd'Heuil D, Jourd'heuil FL, Lowery AM, Hughes J, Grisham MB. 2005. Detection of nitrosothiols and other nitroso species in vitro and in cells. Methods Enzymol 396:118-131.
15. Kawahara K, Gotoh T, Oyadomari S, Kuniyasu A, Kohsaka S, Mori M, Nakayama H. 2001. Nitric oxide inhibits the proliferation of murine microglial MG5 cells by a mechanism involving p21 but independent of p53 and cyclic guanosine monophosphate. Neurosci Lett 310:89-92.
16. Kibbe M, Billiar T, Tzeng E. 1999. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 43:650-657.
17. Kibbe MR, Li J, Nie S, Watkins SC, Lizonova A, Kovesdi I, Simmons RL, Billiar TR, Tzeng E. 2000. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg 31:1214-1228.
18. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U. 1996. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kappaB. J Biol Chem 271:6039-6044.
19. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. 1999. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285:1733-1737.
20. Lala PK, Chakraborty C. 2001. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2:149-156.
21. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN. 1998. Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem 273:33048-33053.
22. Lancaster JRJr, Werner-Felmayer G, Wachter H. 1994. Conduction of nitric oxide synthesis and intracellular nonheme iron-nitrosyl complexes in murine cytokine-treated fibroblasts. Free Radic Biol Med 16:869-870.
23. Li CQ, Wogan GN. 2005. Nitric oxide as a modulator of apoptosis. Cancer Lett 226:1-15.
24. Luperchio S, Tamir S, Tannenbaum SR. 1996. NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radic Biol Med 21:513-519.
25. McLaughlin LM, Demple B. 2005. Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53. Cancer Res 65:6097-6104.
26. Menon SG, Sarsour EH, Spitz DR, Higashikubo R, Sturm M, Zhang H, Goswami PC. 2003. Redox regulation of the GI to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res 63:2109-2117.
27. Messmer UK, Ankarcrona M, Nicotera P, Brune B. 1994. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355:23-26.
28. Miyakawa Y, Matsushime H. 2001. Rapid downregulation of cyclin D1 mRNA and protein levels by ultraviolet irradiation in murine macrophage cells. Biochem Biophys Res Commun 284:71-76.
29. Moellering D, Mc AJ, Patel RP, Forman HJ, Mulcahy RT, Jo H, rley-Usmar VM. 1999. The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: A role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase. FEBS Lett 448:292-296.
30. Nakaya N, Lowe SW, Taya Y, Chenchik A, Enikolopov G. 2000. Specific pattern of p53 phosphorylation during nitric oxide-induced cell cycle arrest. Oncogene 19:6369-6375.
31. Pervin S, Singh R, Chaudhuri G. 2001. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): Potential role of cyclin D1. Proc Natl Acad Sci USA 98:3583-3588.
32. Petit JF, Nicaise M, Lepoivre M, Guissani A, Lemaire G. 1996. Protection by glutathione against the antiproliferative effects of nitric oxide. Dependence on kinetics of no release. Biochem Pharmacol 52:205-212.
33. Pompella A, Visvikis A, Paolicchi A, De TV, Casini AF. 2003. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66:1499-1503.
34. Ranjan P, Heintz NH. 2006. S-phase arrest by reactive nitrogen species is bypassed by okadaic acid, an inhibitor of protein phosphatases PP1/PP2A. Free Radic Biol Med 40:247-259.
35. Rao CV. 2004. Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 555:107-119.
36. Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW. 1980. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 106:55-62.
37. Schafer FQ, Buettner GR. 2001. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30:1191-1212.
38. Schneiderhan N, Budde A, Zhang Y, Brune B. 2003. Nitric oxide induces phosphorylation of p53 and impairs nuclear export. Oncogene 22:2857-2868.
39. Thomas DD, Miranda KM, Espey MG, Citrin D, Jourd'Heuil D, Paolocci N, Hewett SJ, Colton CA, Grisham MB, Feelisch M, Wink DA. 2002. Guide for the use of nitric oxide (NO) donors as probes of the chemistry of NO and related redox species in biological systems. Methods Enzymol 359:84-105.
40. Tirmenstein MA, Nicholls-Grzemski FA, Schmittgen TD, Zakrajsek BA, Fariss MW. 2000. Glutathione-dependent regulation of nitric oxide production in isolated rat hepatocyte suspensions. Antioxid Redox Signal 2:767-777.
41. Villalobo A. 2006. Nitric oxide and cell proliferation. FEBS J 273:2329-2344.
42. Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408:307-310.
43. White AC, Maloney EK, Boustani MR, Hassoun PM, Fanburg BL. 1995. Nitric oxide increases cellular glutathione levels in rat lung fibroblasts. Am J Respir Cell Mol Biol 13:442-448.
44. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001-1003.
45. Wink DA, Nims RW, Darbyshire JF, Christodoulou D, Hanbauer I, Cox GW, Laval F, Laval J, Cook JA, Krishna MC. 1994. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem Res Toxicol 7:519-525.
46. Xu W, Liu L, Smith GC, Charles G. 2000. Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. Nat Cell Biol 2:339-345.
47. Yan Z, Hansson GK. 1998. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 82:21-29.